System uses a series of highly efficient coulometric electrochemical cells to specifically monitor metabolically active small molecule cellular components
Metabolon, a pioneer in the area of metabolomics research, has announced that it has decided to adopt CoulArray technology from ESA as an important component in the company's efforts to identify and monitor small molecule cellular biomarkers of disease and disease treatment.
CoulArray technology is said to be unique, in that it uses a series of highly efficient coulometric electrochemical cells to specifically monitor metabolically active small molecule cellular components.
The CoulArray system can be used to greatly simplify the inherent complexity of metabolomics samples by filtering out mundane, 'housekeeping' cellular components.
The design and properties of the CoulArray also facilitate easy data analysis of these types of often highly complex samples.
In addition, the CoulArray offers the advantage of being able to distinguish minute changes in metabolomics patterns and components.
Walter DiGiusto, CEO of ESA, said, "We are delighted with Metabolon's choice of the CoulArray for use in metabolomics studies.
"Selection of the CoulArray demonstrates the utility of ESA technology in metabolomics studies, and represents the latest development in our work with Metabolon to accelerate their operations and expand their bioanalytical capabilities".
John Ryals, CEO of Metabolon, said, " CoulArray will be a significant component in our metabolomics technology platform.
"We are pleased to continue our relationship with ESA as we move forward in this important science."
